[go: up one dir, main page]
More Web Proxy on the site http://driver.im/ Skip to main content
Log in

The protective effect of epicatechin on experimental ulcerative colitis in mice is mediated by increasing antioxidation and by the inhibition of NF-κB pathway

  • Original Research Article
  • Published:
Pharmacological Reports Aims and scope Submit manuscript

Abstract

Background

Ulcerative colitis (UC) is a chronic inflammatory intestinal disease. It is necessary to find out new effective drugs for UC. In our study epicatechin extracted from grape seed by our institute for the first time could treat UC effectively. Then anti-UC mechanisms of epicatechin were elucidated in vivo and in vitro.

Methods

Dextran sulfate sodium (DSS)-induced acute UC mice model was used to evaluate the activity of epicatechin and its properties against UC. Then its anti-inflammatory and antioxidant effects were evaluated as follows: the concentrations of TNF-α and IL-6 in the colon supernatants were determined by ELISA. NO and MPO were assayed by Griess method and commercial kit respectively. NF-κB were determined by NF-κB-Dependent Reporter Gene Expression Assay and Western Blotting respectively. Antioxidant factors such as SOD, MDA, GSH-Px and CAT were also measured in colon tissues and cell supernatant stimulated by LPS respectively.

Results

In C57BL/6J mice model with DSS-induced UC, epicatechin was able to decrease the disease activity index and colon macroscopic damage index scores, reduce body weight loss, and significantly relieve colon contracture and crypt damage. TNF-α, IL-6, NO, MPO and MDA were reduced in the mice administered epicatechin, whereas antioxidant enzymes showed increased activity in epicatechin-treated mice and cell line respectively. Furthermore, inhibition effect on NF-κB activation by epicatechin were demonstrated in vivo and in vitro.

Conclusions

Epicatechin has inhibitory effect on DSS-induced acute UC. This effect is mainly due to its antioxidant effect and the inhibition of inflammatory molecules related to NF-κB pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
£29.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fiocchi C. Inflammatory bowel disease, etiology and pathogenesis. Gastroenterol 1998;115:182–205.

    Article  CAS  Google Scholar 

  2. Hanauer SB, Baert F. Medical therapy of inflammatory bowel disease. Med Clin North Am 1994;78:1413–26.

    Article  CAS  Google Scholar 

  3. Peyrin-Biroulet L, Deltenre P, Ardizzone S, D’Haens G, Hanauer SB, Herfarth H, et al. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn’s disease: a meta-analysis. Am J Gastroenterol 2009;104: 2089–96.

    Article  CAS  Google Scholar 

  4. Esatbeyoglu T, Wray V, Winterhalter P. Dimeric procyanidins: screening for B1 to B8 and semisynthetic preparation of B3, B4, B6, and B8 from a polymeric procyanidin fraction of White Willow Bark (Salix alba). J Agric Food Chem 2010;58:7820–30.

    Article  CAS  Google Scholar 

  5. Santos-Buelga C, Scalbert A. Proanthocyanidins and tannin-like compoundsnature, occurrence, dietary intake and effects on nutrition and health. J Sci Food Agric 2000;80:1094–117.

    Article  CAS  Google Scholar 

  6. Khanal RC, Howard LR, Prior RL. Procyanidin content of grape seed and pomace, and total anthocyanin content of grape pomace as affected by extrusion processing. J Food Sci 2009;74:H174–82.

    Article  CAS  Google Scholar 

  7. Gu L, Kelm M, Hammerstone JF, Beecher G, Cunningham D, Vannozzi S, et al. Fractionation of polymeric procyanidins from lowbush blueberry and quantification of procyanidins in selected foods with an optimized normal-phase HPLC-MS fluorescent detection method. J Agric Food Chem 2002;50:4852–60.

    Article  CAS  Google Scholar 

  8. Vivas N. Glories isabelle Y: a complete structural and conformational investigation of procyanidin A2 dimer. Tetrahedron Lett 1996;37:2015–8.

    Article  CAS  Google Scholar 

  9. He X, Zheng Z, Yang X, Lu Y, Chen N, Chen W. Tetramethylpyrazine attenuates PPAR-γ antagonist-deteriorated oxazolone-induced colitis in mice. Mol Med Rep 2012;5:645–50.

    CAS  PubMed  Google Scholar 

  10. Joh EH, Lee IA, Jung IH, Kim DH. Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation — the key step of inflammation. Biochem Pharmacol 2011;82:278–86.

    Article  CAS  Google Scholar 

  11. Bancroft JD, Gamble M. Theory and practice of histological techniques. 6th ed. London: Churchill Livingstone; 2008.

    Google Scholar 

  12. Grisham MB, Johnson GG, Lancaster JR. Quantita-on of nitrate and nitrite in extracellular fluids. Methods Enzymol 1996;68:237–46.

    Article  Google Scholar 

  13. Andújar I, Recio MC, Giner RM, Cienfuegos-Jovellanos E, Laghi S, Muguerza B, et al. Inhibition of ulcerative colitis in mice after oral administration of a polyphenol-enriched cocoa extract is mediated by the inhibition of STAT1 and STAT3 phosphorylation in colon cells. J Agric Food Chem 2011;59:6474–83.

    Article  Google Scholar 

  14. Grisham MB. Oxidants and free radicals in inflammatory bowel disease. Lancet 1994;344:859–61.

    Article  CAS  Google Scholar 

  15. Bitiren M, Karakilcik AZ, Zerin M, Ozardali I, Selek S, Nazligül Y, et al. Protective effects of selenium and vitamin E combination on experimental colitis in blood plasma and colon of rats. Biol Trace Elem Res 2010;136:87–95.

    Article  CAS  Google Scholar 

  16. Narushima S, Spitz DR, Oberley LW, Toyokuni S, Miyata T, Gunnett CA, et al. Evidence for oxidative stress in NSAID-induced colitis in IL10−/− mice. Free Radic Biol Med 2003;34:1153–66.

    Article  CAS  Google Scholar 

  17. Ademoglu E, Erbil Y, Tam B, Barbaros U, Ilhan E, Olgac V, et al. Do vitamin E and selenium have beneficial effects on trinitrobenzenesulfonic acid-induced experimental colitis. Dig Dis Sci 2004;49:102–8.

    Article  CAS  Google Scholar 

  18. Karin M, Lin A. NF-kappa B at the crossroads of life and death. Nat Immunol 2002;3:221–7.

    Article  CAS  Google Scholar 

  19. Spehlmann ME, Eckmann L. Nuclear factor-kappa B in intestinal protection and destruction. Curr Opin Gastroenterol 2009;25:92–9.

    Article  CAS  Google Scholar 

  20. Creveling CR. The role of catechol-O-methyltransferase in the inactivation of catecholestrogen. Cell Mol Neurobiol 2003;23:289–91.

    Article  CAS  Google Scholar 

  21. Sutton A, Imbert A, Igoudjil A. The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability. Pharmacogenet Genomics 2005;15:311–9.

    Article  CAS  Google Scholar 

  22. Arab HH, Al-Shorbagy MY, Abdallah DM, Nassar NN. Telmisartan attenuates colon inflammation, oxidative perturbations and apoptosis in a rat model of experimental inflammatory bowel disease. PLOS ONE 2014;9:e97193.

    Article  Google Scholar 

  23. Bonner GF. Using COX-2 inhibitors in IBD: anti-inflammatories inflame a controversy. Am J Gastroenterol 2002;97:783–5.

    Article  Google Scholar 

  24. Rezaie A, Parker RD, Abdollahi M. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause. Dig Dis Sci 2007;52:2015–21.

    Article  Google Scholar 

  25. Patel MA, Patel PK, Patel MB. Effects of ethanol extract of Ficus bengalensis (bark) on inflammatory bowel disease. Indian J Pharmacol 2010;42:214–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to LianQiu Wu or WenJie Wang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, H., Deng, A., Zhang, Z. et al. The protective effect of epicatechin on experimental ulcerative colitis in mice is mediated by increasing antioxidation and by the inhibition of NF-κB pathway. Pharmacol. Rep 68, 514–520 (2016). https://doi.org/10.1016/j.pharep.2015.12.011

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.pharep.2015.12.011

Keywords